GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced first quarter fiscal 2022 results for the period ended March 31, 2022.
Digital World Acquisition Corp. (DWAC:NMQ) was the highest Open End and Miscellaneous Investment Vehicles company headquartered in California on May 20.
Digital World Acquisition Corp. (DWAC:NMQ) was the highest Open End and Miscellaneous Investment Vehicles company headquartered in California on May 20.
The US Department of Transportation's National Highway Traffic Safety Administration along with SMPD want to remind all motorists that May is Motorcycle Safety Awareness Month.
This spring, BCIL Speaker Series on both campuses have given students opportunities to hear inspiring stories from individuals making real world change in their communities.
GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary tri-specific natural killer (NK) cell engager, TriKE® protein biologic technology platform, announced that management will present at H.C. Wainwright’s Hybrid Global Investment Conference